Hyperbaric oxygen: A novel modality to ameliorate experimental colitis

Gut

Volumn 43, Issue 4, 1998, Pages 512-518

  Rachmilewitz, D ^a   Karmeli, F ^a   Okon, E ^a   Rubenstein, I ^b   Better, O S ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Acetic acid colitis; Hyperbaric oxygen; Inflammatory bowel disease; Trinitrobenzenesulphonic acid colitis

Indexed keywords

ACETIC ACID; LEUKOTRIENE B4; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; ENZYME RELEASE; HYPERBARIC OXYGEN; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

EID: 0031690631     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.4.512     Document Type: Article

References (19)

1. Tibbles PM, Edelsberg JS. Hyperbaric oxygen therapy. N Engl J Med 1996;334:1642-8.
2. Zamboni WA, Roth AC, Russell RC, et al. Morphologic analysis of the microcirculation during reperfuson of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 1993;91:1110-23.
3. Yamada T, Taguchi T, Hirata Y, et al. The protective effect of hyperbaric oxygenation on the small intestine in ischemia reperfusion injury. J Pediatr Surg 1995;30:786-90.
4. Lavy A, Weisz G, Adir Y, et al. Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol 1994;19:202-5.
5. Colombel JF, Mathieu D, Bonault JM, et al. Hyperbaric oxygenation in severe perianal Crohn's disease. Dis Colon Rectum 1995;38:609-14.
6. Eliakim R, Rachmilewitz D. Potential mediators in inflammatory bowel disease. Gastroenterology International 1992;5: 48-56.
7. Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36:718-23.
8. Rachmilewitz D, Stamler JS, Karmeli F, et al. Peroxynitrite-induced rat colitis: a new model of colonic inflammation. Gastroenterology 1993;105:1681-8.
9. Rachmilewitz D, Karmeli F, Okon E, et al. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995;37:247-55.
10. Karmeli F, Eliakim R, Okon E, et al. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. Gut 1995;37:386-93.
11. Kurata S, Yamashita U, Nakajima H. Hyperbaric oxygenation reduces the cytostatic activity and transcription of nitric oxide synthetase gene of mouse peritoneal macrophages. Biochim Biophys Acta 1995;1263:35-8.
12. Bush PA, Gonzalez NE, Griscavage JM, et al. Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commun 1992;185:960-6.
13. Bradley PP, Prichat DA, Christensen RD, et al. Measurement of cutaneous inflammation; estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78: 206-9.
14. Sharon P, Ligumsky M, Rachmilewitz D, et al. Role of prostaglandins in ulcerative colitis: enhanced production during active disease and inhibition by sulphasalazine. Gastroenterology 1978;65:638-40.
15. Gabb G, Robin ED. Hyperbaric oxygen therapy in search of diseases. Chest 1987;92:1074-82.
16. Rachmilewitz D, Simon PL, Schwartz LW, et al. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989;97:326-37.
17. Rachmilewitz D, Karmeli F, Okon E. Sulphydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology 1995;109:98-106.
18. Ferreira SH, Moncada S, Vane JR. Prostaglandins and signs and symptoms of inflammation. In: Robinson HJ, Vane JR, eds. Prostaglandin synthetase inhibitors. New York: Raven Press, 1974:175-87.
19. Robert A, Nezamis JE, Lancaster C, et al. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH and thermal injury. Gastroenterology 1979;77:433-43.